Key priority area

Improve access to clinical trials in pancreatic cancer, including for people with metastatic disease

Strategies and activities

Each key priority area has supporting strategies and associated activities for implementation in the short, medium or long term that have been identified to achieve the priority. Click on the strategies below to explore these in more detail.


Promote participation in clinical trials for pancreatic cancer


Short term

  • Promote patient and clinician awareness on the benefits of participation in clinical trials for, people with metastatic disease

  • Identify barriers to patient participation in a clinical trial

Medium term

  • Design and implement standardised approach for routine access to clinical trials, leveraging technology and innovation